Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: A decision analysis

Transplantation

Volumn 72, Issue 5, 2001, Pages 861-868

  J Cheng, Steve ^a   Pratt, Daniel S ^a   Freeman Jr , Richard B ^a   Kaplan, Marshall M ^a   Wong, John B ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CADAVER DONOR; HUMAN; INOPERABLE CANCER; LIFE EXPECTANCY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONOR; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROBABILITY; RISK BENEFIT ANALYSIS; STATISTICAL MODEL; SURVIVAL RATE; SYSTEM ANALYSIS;

EID: 0035884712     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200109150-00021     Document Type: Article

References (77)

1. Hepatocellular carcinoma
2. Epidemiology of hepatocellular carcinoma
3. Rising incidence of hepatocellular carcinoma in the United States
4. Hepatocellular carcinoma in Italian patients with cirrhosis
5. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation
6. Liver transplantation for hepatocellular carcinoma
7. Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure
8. Practical considerations in the treatment of hepatocellular carcinoma
9. A randomized prospective multi-institutional trial of orthotopic liver transplantation or partial hepatic resection with or without adjuvant chemotherapy for hepatocellular carcinoma
10. Appendix C: Current liver allocation policies
11. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients
12. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
13. Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power
14. Should hepatomas be treated with hepatic resection or transplantation?
15. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: A comparative study
16. Analysis of waiting times
17. Living related liver transplantation
18. Right lobe living donor liver transplantation
19. Liver transplantation using a right lobe graft from a living related donor
20. Adult-to-adult living donor liver transplantation using extended right lobe grafts
21. Right lobe graft in living donor liver transplantation
22. Technical refinement in adult-to-adult living donor liver transplantation using right lobe graft
23. Adult living donor liver transplantation using a right hepatic lobe
24. Ethical issues in living related donor liver transplantation
25. Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival
26. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis
27. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications
28. United States life tables, 1997
29. A convenient approximation of life expectancy (The "DEALE") I. Validation of the method
30. Probabilistic sensitivity analysis using Monte Carlo simulation
31. Asymptomatic hepatocellular carcinoma in Child's A cirrhosis
32. Clinical decision making rounds at the New England Medical Center. The timing of radical cystectomy after recent myocardial infarction: Waiting for Godot
33. Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases
34. Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials
35. Prognostic factors of hepatocellular carcinoma in the West: A multivariate analysis in 206 patients
36. Compensated cirrhosis: Natural history and prognostic factors
37. Survival and prognostic indicators in compensated and decompensated cirrhosis
38. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis
39. Evaluation of hepatic function in liver cirrhosis: Clinical utility of galactose elimination capacity, hepatic clearance of d-sorbitol, and laboratory investigations
40. The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States
41. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
42. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome-oriented decision analysis
43. Results of orthotopic liver transplantation for liver cirrhosis in the presence of incidental and/or undetected hepatocellular carcinoma and tumour characteristics
44. Recurrence-free survival after liver transplantation for small hepatocellular carcinoma
45. An active liver transplant programme for hepatocellular carcinoma in cirrhotic patients: Is it justified?
46. Liver transplantation for hepatocellular carcinoma
47. Liver transplantation for hepatocellular carcinoma in cirrhosis
48. The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver
49. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: A retrospective analysis
50. Role of liver transplantation in cancer therapy
51. Liver transplantation for malignant disease. Results in 93 consecutive patients
52. Hepatic transplantation for primary and metastatic cancers of the liver
53. The role of liver transplantation in hepatobiliary malignancy
54. Liver transplantation for hepatocellular carcinoma
55. Liver transplantation for hepatocarcinoma
56. Primary treatment of hepatocellular carcinoma by arterial chemoembolization
57. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution
58. Nonsurgical treatment of hepatocellular carcinoma
59. Neoadjuvant intra arterial chemotherapy for unresectable primary and secondary liver tumors. Results of a 4 years prospective study
60. Clinical outcome of living-related-donor liver transplantation for adult recipients in Japan
61. Lack of relationship between preoperative measures of severity of cirrhosis and short-term survival after liver transplantation
62. Child-Pugh score and liver transplantation
63. Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted?
64. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery
65. Probabilistic sensitivity analysis incorporating the bootstrap: An example comparing treatments for the eradication of Helicobacter pylori
66. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation
67. Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center
68. Operative risks of major hepatic resections
69. Cavernous hemangioma of the liver: Anatomic resection vs. enucleation
70. Giant hemangiomas of the liver: Surgical treatment by liver resection
71. Surgical treatment of giant cavernous hemangioma liver
72. Hepatectomy including more than half of liver volume with intermittent portal triad occlusion
73. Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective